LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-03. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
== Ductal network == The ductal pancreas network originates from the central pancreatic duct—this main duct with the bile duct opens into the duodenum. The ductal cells of the main pancreatic duct are bound by connective tissue and produce a columnar epithelium. Interlobular ducts originate from the main pancreatic duct and connect the various pancreatic lobes. In these lobes, the intercalated ducts expel acini. Meanwhile, the ductal cells of these intercalated ducts create a simple squamous epithelium that rapidly converts into simple cuboidal epithelium, and connective tissue also surrounds them. As the ducts grow larger, the epithelium becomes cuboidal or columnar (when large in diameter, the ducts become stratified cuboidal), and connective tissue surrounds them. Pancreatic ductal cells are very similar to ductal cells of other exocrine glands (liver, bile duct, salivary glands). Because of this, a common diagnosis affects these cells: cystic fibrosis.
The Meghalaya Legislative Assembly is the unicameral legislature of the Indian state of Meghalaya. Constituted as a directly elected body in 1972, it has 60 members, filled through direct elections held every five years. Like other Indian states, Meghalaya has a parliamentary system of government. The executive branch of the Meghalaya Government is derived from the Legislative Assembly.
Baby Burger: small beef patty (1.6 ounces (45 g)), ketchup, unseeded hamburger bun, (optional) cheese slice Mama Burger: regular beef patty (3 ounces (85 g)), onion slice, pickles, ketchup, mustard, Teen Sauce, sesame seed bun, (optional) cheese slice Teen Burger: regular beef patty (3 ounces (85 g)), onion slice, pickles, ketchup, mustard, bacon, Teen Sauce, lettuce, tomato, sesame seed bun, cheese slice Papa Burger: two regular beef patties (6 ounces (170 g) total), onion slice, pickles, ketchup, mustard, Teen Sauce, sesame seed bun, (optional) cheese slice Grandpa Burger: three regular beef patties (9 ounces (260 g) total), onion slice, pickles, ketchup, mustard, Teen Sauce, sesame seed bun, (optional) cheese slice
Normorphine is an opiate analogue, the N-demethylated derivative of morphine, that was first described in the 1950s when a large group of N-substituted morphine analogues were characterized for activity. The compound has relatively little opioid activity in its own right, but is a useful intermediate which can be used to produce both opioid antagonists such as nalorphine, and also potent opioid agonists such as N-phenethylnormorphine. with its formation from morphine catalyzed by the liver enzymes CYP3A4 and CYP2C8. Normorphine is a controlled substance listed under the Single Convention On Narcotic Drugs 1961 and the laws in various states implementing it; for example, in the United States it is a Schedule I Narcotic controlled substance, with an ACSCN of 9313 and an annual aggregate manufacturing quota of 18 grams in 2014, unchanged from the prior year. The salts in use are the free base hexahydrate (free base conversion ratio 0.715), and hydrochloride (0.833).
Sources: en.wikipedia.org
A nuclide is a more general term than isotope, and refers to atoms that have any particular number of protons and neutrons. Stable nuclides are not radioactive and do not spontaneously undergo radioactive decay, so are more usually found in nature. Whereas unstable (i.e. radioactive) nuclides are not found in nature, unless there is a recent source of them, because they are shorter lived, and will spontaneously decay, in one or more steps, to more stable nuclides. For example, carbon-14 is unstable but is found in nature. Scientists use accelerators and nuclear reactors to produce radioactive nuclides. As a general trend, and among other factors, the neutron–proton ratio of a nuclide determines its stability. The value of this ratio for stable nuclides generally increases for larger nuclei with more protons and neutrons. Many unstable nuclides have neutron-proton ratios beyond the zone of stability. The time required to lose half of a quantity of a given nuclide through radioactive decays, the half-life, is a measure of how stable an isotope is. Nuclides can be visually represented on a table (Segré chart or table of nuclides) where the proton number is plotted against the neutron number.
It is a molecular metal oxide, analogous to manganese heptoxide. It adopts a centrosymmetric structure with two types of Tc–O bonds with 167 and 184 pm bond lengths. Technetium heptoxide hydrolyzes to pertechnetate and pertechnetic acid, depending on the pH:
==== Supramolecular ==== Streptavidin or avidin in combination with biotinylated artificial metal cofactors is the most commonly used supramolecular strategy to make ArMs. In the early example from Ward et al. shown below, the ligand of Ru(I) complex was covalently linked to biotin and then the whole complex was anchored to streptavidin thanks to a specific and strong biotin-streptavidin interaction. The formed ArM can catalyze the reduction of prochiral ketones. Taking advantages of protein evolvability, different mutants of streptavidin can achieve different stereoselectivity. Throughout the years, many streptavidin-based enzymes were developed, enabling catalysis of very complex transformations in water, under ambient conditions. Besides biotin-streptavidin based ArMs, another important example of using supramolecular iassembly strategy is antigen-antibody recognition. First reported in 1989 by Lerner et al.., a monoclonal antibody-based ArM is raised to hydrolyze specific peptide.
Sources: en.wikipedia.org
For services to the community in Martlesham, Suffolk. Brian Francis Bryceland, Senior Executive Officer, Department of Social Security. Cyril Percy Bunn. For services to Journalism in Cornwall. Christine Dorothe Burges. For services to Young People in Edenbndge, Kent. John Christopher Burne, Voluntary Observer, Meteorological Office, Kent. Patricia Rose Burnett. For services to Service Families in Hereford. Susan Marilyn Burns. For services to the Rela Goldhill Lodge, London and to Young Disabled People. Herbert Roy Butler. For services to the community in Frome, Somerset. William Anthony Butler. For political service. Maxwell Charles Cadmore. For services to Health Care in Swansea, South Wales. Walter Rounsfell Cairns, lately Literature Director, Scottish Arts Council. For services to Literature. William Martin Calderbank. For services to the Engineering Industry. Joseph Graham Campbell. For services to the community. Reginald John Cann, lately Maintenance Supervisor, Crown Estate Commissioners. Harold Canning, Chairman, Wolverhampton and Walsall Committee for the Employment of People with Disabilities. For services to the Employment of Disabled People. Pamela Kathleen Cannon, Revenue Typist, Board of Inland Revenue. Peter Andrew Carruthers. For services to Sport for People with Disabilities. Mary Shane Casement. For services to the Rehabilitation of Offenders. Allan Lewis Chambers. For services to Agriculture. Derek Chambers, Senior Investigation Officer, Her Majesty's Board of Customs and Excise.
== Leaders of Opposition == Official Opposition is a term used to designate the political party which has secured the second largest number of seats in the assembly. In order to get formal recognition, the party must have at least one-sixth of the total number of Members of the House as required under the aforementioned provisions. However, On 16 May 2026, the Assam Legislative Assembly amended its rules to lower the eligibility threshold for the Leader of the Opposition from one-sixth to one-tenth of the total membership. As a result, a party now requires at least 13 MLAs instead of 21 to qualify, enabling the Indian National Congress, despite its reduced strength, to appoint a Leader of the Opposition in the Assembly.
West Yorkshire also used to host regular speedway meetings, having the Halifax Dukes and the Bradford Dukes teams. Odsal Stadium used to host BriSCA stock cars. Leeds has a hill climb event at Harewood speed Hillclimb.
==== Gram-negative bacteria ==== Outer membrane vesicles (OMVs), that can transfer DNA between bacterial cells, are produced by metabolically active bacterial cells, and the OMVs are not the result of cell lysis or cell death. Pathogenic strains can produce about 10-25 times more vesicles than a nonpathogenic strain making this highly relevant to carbapenem resistance transfer. OMVs protect plasmids from being digested extracellularly by nucleases that may be found in the environment, thus favoring horizontal gene transfer.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.